 Go to Previous Investments |
|
|
FlowMedica, Inc | www.flowmedica.com FlowMedica seeks to address a critical and underserved clinical need: renal protection during surgical procedures such as angiography that require contrast agents. FlowMedica’s proprietary infusion systems target renal therapeutics directly to the kidneys, thereby minimizing the potentially harmful systemic effects of nephrotoxic agents. |
|
IMCOR Pharmaceutical Company (formerly Photogen, Inc.) | (NASDAQ: ICPHC) | www.imcorpharma.com IMCOR Pharmaceutical Company is a specialty pharmaceutical company focused on developing and marketing medical imaging pharmaceutical products that are both internally developed and acquired through licensing and acquisition. |
|
Quick Study Radiology, Inc. | www.qs-r.com Quick Study Radiology delivers solutions that permit community hospitals to adopt cutting edge information systems. QSR helps its clients improve care by providing the same cutting-edge PACS, RIS, web distribution and archive technology as large facilities, but with unmatched costs and extraordinary customer support. |
|
superDimension, Ltd. | www.superdimension.com superDimension is an emerging leader in the minimally-invasive diagnosis and treatment of lung disease via CT-guided bronchoscopy.The superDimension/Bronchus system addresses one of the most critical needs in the field: accessing previously unreachable peripheral lung locations in a minimally-invasive manner to improve clinical outcomes. |
|
VueSonix, Inc. | www.vuesonix.com VueSonix has developed a fully digital 3D Doppler ultrasound system that images and measures blood movement in the body noninvasively. This breakthrough radically improves the speed and accuracy of diagnosis and pretreatment planning.This is accomplished with a frame rate that exhibits the full heart cycle allowing quantitative analysis of the peripheral vascular system, radically improving the speed and accuracy of diagnosis. |